-

Hims & Hers Expands Support for Men’s Sexual Wellness With Introduction of Climax Delay Wipes

Non-prescription offering provides Hims customers with a new, medically-backed treatment option for common sexual health issue affecting up to 39% of male population

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today introduced Climax Delay Wipes as a new non-prescription offering within Hims’ Sexual Health category on forhims.com. The non-prescription single-use benzocaine wipes provide a simple and effective way to maintain erections for longer periods of time.

“Nearly 1 in 4 men experience some form of premature ejaculation and up to 40% wish they had more control over their climax,” said Dr. Pete Stahl, SVP of Men’s Sexual Health & Urology at Hims & Hers. “Our new wipes join our line-up of sexual health products like our existing Climax Delay Spray to provide Hims consumers with another option to improve their sexual quality of life by giving them better control in the bedroom and a more delayed climax."

In addition to the new Climax Delay Wipes, Hims provides several solutions targeting climax delay including non-prescription Climax Delay Spray as well as access to both daily and as-needed premature ejaculation prescriptions (available if prescribed by a healthcare provider after a telehealth consultation on forhims.com). Hims & Hers also offers a host of other prescription and non-prescription sexual health products and services, including access to treatment for erectile dysfunction, genital herpes and cold sores, condoms and lubricants, vibrators and birth control pills.

"We’re thrilled to be offering a new non-prescription sexual health offering that can help men feel better and more confident about themselves,” said Andrew Dudum, CEO and Co-Founder, Hims & Hers. “It's our goal to offer access to a variety of treatment options - both prescription and not - so our customers can truly tailor their treatment plans in ways best for them. The Climax Delay Wipes are a reflection of our work to make personalized healthcare more accessible."

For more information about the Climax Delay Wipes, visit https://www.forhims.com/benzocaine-wipes and to learn more about Hims treatment options for premature ejaculation, visit https://www.forhims.com/premature-ejaculation.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O'Connor
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers introduced Climax Delay Wipes as a new non-prescription offering within Hims’ Sexual Health category on forhims.com.
Release Versions

Contacts

Linda O'Connor
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health,...

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advance...

Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on the earlier acquisitions of ZAVA and Livewell, Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France, Germany, Ireland, Spain, and Japan. Continuing to expand internationally will enable Hims & Hers to lead the next...
Back to Newsroom